Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Content Filter
Choose a Topic
Agreement
Appointment
Big Data
Biosimilars
Business
Capacity Expansion
CDMO
Cell and Gene Therapy
Clinical Trials
Collaboration
Continuous Manufacturing
CRISPR
CRO
DNA
Drug Delivery
Drug Development
Drug Discovery
Engineering
Equipment
Excipients
Facility
Formulation
Generics
Healthcare
Immunotherapy
Innovation
Investment
Licensing
Logistics
Manufacturing
Market Expansion
Market Intelligence
Market Prediction
Oncology
Oral Solid Dosage
Orphan Drugs
Packaging
Parenterals
Preclinical
Process Development
Regulatory
Research
Serialization
Stem Cells
Strategic Partnership
Supply Chain
Vaccine
Intermediates
×
Choose a Section
Features
News
Press Releases
Roundtable
In Conversation
Nice Consulting
Virtual Panel
Trends Trending
×
Choose an Issue
Issue Q3 2022
Issue Q2 2022
Issue Q1 2022
Issue Q4 2020
Issue Q3 2020
Issue Q2 2020
Issue Q1 2020
Issue Q4 2019
Issue Q3 2019
Issue Q2 2019
Issue Q1 2019
Issue Q4 2018
Issue Q3 2018
Issue Q2 2018
Issue Q1 2018
Issue Q4 2017
Issue Q3 2017
Issue Q2 2017
Issue Q1 2017
Issue Q4 2016
Issue Q3 2016
Issue Q2 2016
Issue Q1 2016
Issue Q4 2015
×
5840 Articles Available
2
244
Can't find what you're looking for? Try our
advanced search
.
Pediatric Clinical Trials
Pediatric Clinical Trials: Considerations for Enrollment and Retention
PAO-02-24-CL-04
Digital Pathology
Advancing Disease Research and Drug Development on an Enterprise Pathology Software Platform
PAO-01-24-CL-2
Portable CMC
Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use
PR-M02-29-01
Advanceability
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
PAO-02-24-CL-09
3D Printing
Exploring New Possibilities with 3D Printing of Pharmaceuticals
PAO-02-24-CL-11
Lentivirus Production
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
PR-M02-05-02
CDMO - Small Biotech
Cis-Targeted Immunotherapies Need Large CDMO Expertise But Also Flexibility
PAO-02-24-CL-07
Tech Transfer
Transparent Communication Supports Tech Transfers Of Cis-targeted Immunotherapies
PAO-02-24-CL-06
Biologics Formulation
Successful Formulation Development for Biologics Using a Unique Biophysical Prediction and Screening Platform
PAO-02-24-CL-02
Translation
The Translational Index Score: Improving the Entire Drug Development Cycle
PAO-02-24-CL-10
Cell-Free
Cell-Free Protein Synthesis Holds Real Potential to Transform Drug Development and Manufacturing
PAO-02-24-NI-01
Robotic Sterile Fill-Finish
Reducing Time to First-in-Human Trials with Robotic Sterile Fill-Finish Manufacturing Services
PAO-02-24-CL-03
CMC
Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform
PAO-12-23-CL-04
Synthetic DNA
Is Synthetic Plasmid DNA One of the Solutions for Meeting Growing Demand for Next-Gen Therapies?
PAO-01-24-NI-04
High Potency API Suite
Expanding Capabilities for Clients:Olon to Open New High Potency API Suite in US
PR-M02-24-01
CDMO Rebranding
Suanfarma Unifies Its Industrial Brands in a Rebranding Initiative Under Suanfarma CDMO
PR-M01-24-03
Genomics
Integrated Spatial Genomics: Real Potential to Provide Truly Novel Biological Insights
PAO-01-24-NI-03
CDMO
Advanced Technologies Unlocking the Future of Drug Manufacturing
PAO-03-24-CL-04
Recombinant Antibody
Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma
PAO-01-24-CL-4
New Packaging
Consistent Formulation, Continuous Improvement: Introducing Robust, Easier-to-Use Detergent Packaging
PAO-01-24-CL-3
Molecular Machines
The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond
PAO-01-24-NI-02
Appointment
SGD Pharma Announces the Appointment of Fabio Invernizzi, General Manager West Business Unit
PR-M01-24-02
CDMO
Vetter becomes a member of the German Association of Research-Based Pharmaceutical Companies (vfa)
PR-M01-24-01
Decentralized Clinical Trials
An Adaptive Ecosystem of Solutions: Evolving Clinical Trials in a Decentralized World
PAO-12-23-CL-08
«
2
244
»